Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)
Clinical trial NCT06770855 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06770855
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-09-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.